As of May 27
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for VolitionRX Ltd have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +202.11% increase from the last price of 3.31.
The current consensus among 3 polled investment analysts is to Buy stock in VolitionRX Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.